| Literature DB >> 27313869 |
Alahmady Hamad Alsmman Hassan1, Khulood M Sayed1, Mohammed ElAgooz1, Ashraf Mostafa Elhawary1.
Abstract
In this study we evaluate the visual outcomes, safety, efficacy, and stability of implanting of second sulcus intraocular lens (IOL) to correct unsatisfied ametropic patients after phacoemulsification. Methods. Retrospective study of 15 eyes (15 patients) underwent secondary intraocular lens implanted into the ciliary sulcus. The IOL used was a Sensar IOL three-piece foldable hydrophobic acrylic IOL. The first IOL in all patients was acrylic intrabagal IOL implanted in uncomplicated phacoemulsification surgery. Results. Fifteen eyes (15 patients) were involved in this study. Preoperatively, mean logMAR UDVA and CDVA were 0.88 ± 0.22 and 0.19 ± 0.13, respectively, with a mean follow-up of 28 months (range: 24 to 36 months). At the end of the follow-up, all eyes achieved logMAR UDVA of 0.20 ± 0.12 with postoperative refraction ranging from 0.00 to -0.50 D of attempted emmetropia. Conclusions. Implantation of the second sulcus SensarAR40 IOL was found to be safe, easy, and simple technique for management of ametropia following uncomplicated phacoemulsification.Entities:
Year: 2016 PMID: 27313869 PMCID: PMC4904093 DOI: 10.1155/2016/4505812
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
The collected data for each case.
| Case number | Age | Sex | Eye | Error SE | UDVA | CDVA | Duration of surgery | PMMA IOL power | Postop. SE | Postop. vision | Follow-up |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 63 | f | Od | −2 | 6/24 | 6/9 | 5 m | −2 | −0.25 | 6/9 | 26 m |
| 2 | 56 | f | Od | −3 | 6/36 | 6/9 | 7 m | −3 | 0.00 | 6/9 | 28 m |
| 3 | 42 | m | Od | −1.5 | 6/12 | 6/6 | 14 m | −1.5 | 0.00 | 6/6 | 24 m |
| 4 | 68 | m | Os | +3 | 6/60 | 6/12 | 4 m | +4.5 | 0.25 | 6/12 | 30 m |
| 5 | 58 | f | Od | −2.5 | 6/36 | 6/9 | 6 m | −2.5 | 0.00 | 6/9 | 28 m |
| 6 | 56 | m | Os | +2.5 | 6/60 | 6/9 | 18 m | +4 | −0.5 | 6/9 | 29 m |
| 7 | 49 | f | Od | −4 | 6/36 | 6/9 | 1 m | −4 | −0.25 | 6/9 | 36 m |
| 8 | 70 | f | Od | −7 | 5/60 | 6/18 | 12 m | −7 | −0.1 | 6/18 | 33 m |
| 9 | 54 | m | Od | +3.5 | 5/60 | 6/9 | 6 m | +5.5 | −0.5 | 6/9 | 27 m |
| 10 | 64 | f | Os | +2.5 | 6/60 | 6/12 | 5 m | +4 | −0.25 | 6/12 | 34 m |
| 11 | 66 | f | Od | +4.5 | 4/60 | 6/12 | 12 m | +7 | −0.5 | 6/12 | 26 m |
| 12 | 59 | f | Os | +3 | 6/60 | 6/9 | 16 m | +4.5 | 0.00 | 6/9 | 32 m |
| 13 | 60 | m | Os | +2 | 6/36 | 6/9 | 22 m | +3 | 0.00 | 6/9 | 29 m |
| 14 | 50 | m | Od | −3 | 6/36 | 6/6 | 30 m | −3 | −0.25 | 6/6 | 24 m |
| 15 | 55 | m | os | +3 | 6/60 | 6/6 | 7 m | +4.5 | −0.5 | 6/9 | 27 m |
SE: spherical equivalent, UDVA: uncorrected distant visual acuity, CDVA: corrected distant visual acuity, and Postop.: postoperative.
Patients demographic data.
| Range | Mean | |
|---|---|---|
| Age | 42–70 | 58 ± 7.60 |
| Error | 4.50 to −7.00 | −0.23 ± 3.82 |
| UDVA | 0.30–1.18 | 0.88 ± 0.22 |
| CDVA | 0.00–0.48 | 0.19 ± 0.13 |
| Duration | 1.00–30.00 | 11 ± 7.88 |
| IOL power | −7.00–7.00 | 0.93 ± 4.34 |
| Refpost | −0.50 to 0.25 | −0.19 ± 0.24 |
| POSTVA | 0.00–0.48 | 0.20 ± 0.12 |
| Follow-up | 24–36 | 28.88 ± 3.56 |
UDVA: uncorrected distant visual acuity, CDVA: corrected distant visual acuity, and Postop.: postoperative.
Figure 1Pre- and postoperative vision in last visit.
Figure 2Pre- and postoperative refraction in last visit.
Correlations.
|
|
| ||
|---|---|---|---|
| UCVA | Age | 0.630 | 0.12 |
| CDVA | 0.564 | 0.028 | |
| IOL power | 0.643 | 0.01 | |
| Postop. VA | 0.675 | 0.006 | |
|
| |||
| Error | IOL power | 0.997 | 0.00 |
|
| |||
| CDVA | Age | 0.835 | 0.00 |
| UCVA | 0.564 | 0.028 | |
| Postop. VA | 0.935 | 0.00 | |
| Follow-up | 0.582 | 0.023 | |
|
| |||
| Postop. VA | Age | 0.869 | 0.00 |
| UDVA | 0.675 | 0.006 | |
| CDVA | 0.935 | 0.000 | |
| Follow-up | 0.578 | 0.024 | |
UDVA: uncorrected distant visual acuity, CDVA: corrected distant visual acuity, and Postop.: postoperative.